Skip to content

Clinical trials

Recruiting Aortic Valve Stenosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aortic Valve Stenosis Status: Recruiting Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20181
20203
20212
20222
20234
20244
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Center for Cardiovascular Diseases4
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Beijing Anzhen Hospital2
Novartis Pharmaceuticals2
Shanghai MicroPort CardioFlow Medtech Co., Ltd.2
Xijing Hospital2
Beijing Balance Medical Technology Co., Ltd1
Chengdu Silara Meditech Inc.1
Chinese Academy of Medical Sciences, Fuwai Hospital1
Mitrassist Lifesciences Limited Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aortic Valve Stenosis27
Aortic Valve Disease6
Aortic Valve Insufficiency4
Bicuspid Aortic Valve Disease3
Cardiovascular Diseases2
Dyslipidemias2
Heart Failure2
Heart Valve Diseases2
Hypercholesterolemia2
Hyperlipidemias2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.